Texas Oncology — Bedford, Texas

Texas Oncology is a clinical research site located in Bedford, Texas, United States 76022.

Crixeo Clinical Trials Trust Score: 20/100 (FAILING). This profile has not yet been claimed by the site owner.

Texas Oncology has participated in 17 clinical trials with 3 currently active.

Therapeutic areas: Breast Cancer, Platinum Resistant Ovarian Cancer, Ovarian Cancer.

Sponsors: Genentech, Inc., Mateon Therapeutics, Hoffmann-La Roche.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Bedford

Browse all research sites in Texas · View every site in Bedford

• Texas Health Harris Methodist Hospital Hurst-Euless-Bedford
• Texas Oncology Bedford 1609 Hospital Parkway
• Texas Health Harris Methodist Hurst-Euless-Bedford Hospital
• Texas Oncology Bedford
• Texas Oncology P A
• Research Site
• GSK Investigational Site
• Center for Assisted Reproduction
• Texas Oncology P A Bedford
• Pfizer Investigational Site
• Novartis Investigative Site

Sponsor Feasibility Report

Trust Score: 20/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Texas Oncology?

Texas Oncology has a Crixeo Trust Score of 20/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Texas Oncology conducted?

Texas Oncology has 17 clinical trials on record, with 3 currently active. Their work covers Breast Cancer, Platinum Resistant Ovarian Cancer, Ovarian Cancer.

Is Texas Oncology accredited by Crixeo Clinical Trials?

Texas Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Texas Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.